Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which catheter wins? new study seeks patient preferences

NCT ID NCT07355803

Knowledge-focused Sponsor: Coloplast NV/SA Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times

Summary

This study looks at how adults with bladder problems decide which Coloplast catheter (SpeediCath or Luja) works best for them when they start self-catheterization. Researchers will track satisfaction and challenges over six months. The goal is to help healthcare providers recommend catheters that better fit patients' needs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

22 people

The number who actually took part.

Started

Oct 2025

Finished

Aug 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female or male aged eighteen years or older; * Written informed consent; * Subject affiliated with a social security scheme or beneficiary; * Subject with neurogenic or non-neurogenic bladder issues, justifying the implementation of intermittent self-catheterisation (ISC) to clean out the bladder; * Subject who received his/her initial ISC training at the time of inclusion; * Subject for whom the expected ISC duration is at least six months; * Subject for whom at least two types of Coloplast catheters have been introduced and who has chosen to use Coloplast catheters as the first catheter for self-catheterisation; * Subject able to independently conduct ISC; * Subject for whom the healthcare professional has recommended to conduct ISC at least four times per day. Exclusion Criteria: * Vulnerable subject with regard to the current regulation: * Pregnant, parturient or breast-feeding woman; * Subject deprived of freedom by judicial, medical or administrative decision; * Underage subject; * Subject is legally protected or unable to express his/her consent; * Subject not affiliated with or not a beneficiary of a social security scheme; * Subject falling into several categories above; * Subject who refused to participate in the study; * Subject participating in an interventional clinical study; * Subject who, according to the investigator, has cognitive problems that prevent him/her from completing a questionnaire or for whom the assessment may be a problem.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder dysfunction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hinman syndrome urinary bladder disorder urinary bladder, atony of Urinary Bladder, Neurogenic Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder dysfunction Neurogenic bladder disorder Non-neurogenic bladder Urinary retention

Contacts and locations

Locations

  • UZ Leuven

    Leuven, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.